In this study, we have discovered a novel OGT-MITF-mediated pathway that plays a crucial role in regulating MITF transcriptional activity and conferring resistance to CDK4/6 inhibitors in breast cancer. This evidence concerns the gene CDK4 and breast carcinoma.